Viewing Study NCT03056833


Ignite Creation Date: 2025-12-25 @ 2:49 AM
Ignite Modification Date: 2026-02-26 @ 6:28 AM
Study NCT ID: NCT03056833
Status: COMPLETED
Last Update Posted: 2022-09-07
First Post: 2017-02-14
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Ribociclib (Ribociclib (LEE-011)) With Platinum-based Chemotherapy in Recurrent Platinum Sensitive Ovarian Cancer
Sponsor: Ronald Buckanovich
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Fallopian Tube Cancer View
None Peritoneal Carcinoma View
Keywords: